Entourage Health Corp. shareholders approve going-private plan

Entourage Health Corp. has announced that its shareholders have approved a plan for the company to go private. This decision was made during a special meeting held on March 21, 2025. Under the plan, a related company will buy all of Entourage's common shares for $0.005 each. The vote was overwhelmingly in favor of the plan, with over 95% of those present supporting it. The arrangement will need to receive final approval from the Ontario Superior Court to proceed. If successful, the transition is expected to be finalized by March 31, 2025. Once the transaction is completed, Entourage’s shares will be delisted from the TSX Venture Exchange. The company will also stop being a reporting issuer under Canadian securities laws. Shareholders will need to submit their share certificates to receive the cash payment. Entourage Health Corp. produces and distributes cannabis products for medical and adult-use markets. They operate a processing facility in Aylmer, Ontario, and have partnerships to enhance their distribution strategy.